Visceral leishmaniasis is an endemic parasitic disease transmitted by the bite of the sand fly vector caused by different species of Leishmanias genera. It used to appear in positive HIV patients who have CD4 cell count under 200 Â 10 6 /L. However, visceral leishmaniasis cases have also been described in patients with acquired immunodeficiency, such as those patients who had undergone transplantation. [1] [2] [3] [4] The most usual signs are fever, pancytopenia, general unwellness and hepatosplenomegaly. The effects on the gastrointestinal tract are less common but include diarrhoea, abdominal discomfort, nausea and weight lost. 5 It can affect any segment of gastrointestinal tract, but the most common location is the duodenum. There is no characteristic endoscopic image. The diagnosis is histological, by identifying the parasite inside macrophage cells of gastrointestinal lamina propria. 6, 7 In November 2010, a 49-year-old gypsy woman from Romania was diagnosed with AML with complex karyotype. She was treated according to protocol PETHEMA LAM-2007 reaching a CR after induction and later, she received 2 intensification courses without noteworthy complications. In June 2011, she underwent an allogeneic umbilical cord blood (UCB) SCT from an HLA mismatched unrelated donor (5/6), after reducedintensity conditioning (rabbit-ATG 8 mg/kg, fludarabine 150 mg/m 2 , thiotepa 5 mg/kg, BU 6.4 mg/kg i.v.). GVHD prophylaxis consisted of CYA plus prednisone (1 mg/kg once daily) and as infectious prophylaxis she received levofloxacin, acyclovir and voriconazole. Complications in the immediate post-SCT period were GVHD grade III, pulmonary invasive fungal infection (Aspergillus sp) treated with liposomal amphotericin B and CMV reactivation with good response to valganciclovir therapy.
On day þ 160 after SCT, the patient was admitted to the hospital because of fever up to 39 1C with chills and malaise in the last 10 days. She referred dysphagia and odynophagia as well, with painful lesions in oral mucosa and difficulty in eating and taking medication. In addition, she complained of abdominal pain locating in the epigastrium, with nausea and vomiting without diarrhoea. She currently was under CYA 100 mg twice daily and prednisone (Taper schedule, 0.5 mg/kg). On examination, there was frank jaundice, highlighting a large ulcer on the lower lip and oral mucosa of upper palate, as well as significant pain on palpation in the epigastrium and right hypochondrium. Liver and spleen sizes and echogenicity were normal, without lesions. Normal pancreas and retroperitoneum. Kidneys cortical echogenicity slightly increased (consistent with medical renal disease). No free i.p. fluid.
Upon arrival, because of oral lesions highly suspicious of HSV reactivation, she was treated with acyclovir at dose of 10 mg/kg three times daily. Treatment with tenofovir was initiated 3 days later admission, reaching a negative PCR for HBV within 2 weeks. However, despite initial improvement of mouth sores, oral lesions worsened and she continued with increasing odinophagia, nausea, vomiting and worsening pancytopenia. An upper endoscopy was performed, which identified, about 30 cm from the dental arch, an oval ulcer of about 6 mm in diameter. The macroscopic appearance of duodenal bulb and stomach mucosa was normal. The result of pathology, objectified mild intestinal chronic inflammation in duodenal mucosa and presence of histiocytes in the lamina propria with abundant intra-cytoplasmic oval microorganisms suggestive of amastigotes of Leishmania (Figure 1 ). Oral lesions were biopsied, taking samples for pathology and microbiology. Qualitative-PCR was positive for Leishmania and for HSV but pathological result was not conclusive. A BM smear displayed a marked infiltration of Leishmania amastigotes inside and outside the hystiocytes without dysplasia. Because of torpid evolution of oral ulcers and CMV-PCR became positive (1565 copies/mL) foscarnet was substituted by acyclovir without improvement (Figure 2) .
After the diagnosis of visceral leishmaniasis, treatment with liposomal amphotericin B was started, 4 mg/kg once daily i.v. reaching a target dose of 48 mg/kg. The control myelogram performed at 20 days of treatment followed showing Leishmania, so liposomal amphotericin is replaced by meglumine antimoniate (Glucantime).
Haematologically, although the neutrophil count was normal, she developed severe thrombocytopenia (platelets below 10 Â 10 9 /L) and hyporegenerative anaemia despite treatment with darbopoetin. Moreover, despite initial improvement of liver function after treatment with tenofovir, there was a later decline, reaching levels Figure 1 . Macrophages with intra-cytoplasmic Leishmania amastigotes in lamina propria of the duodenum (Haematoxylin Eosin staining Â 1000).
of bilirubin of 598.6 mmol/L, alkaline phosphatase of 1195 IU/L and GGT around 1000 IU/L. Transjugular liver biopsy was performed and the pathological result was consistent with GVHD. Thus, methyl-prednisolone at a dose of 2 mg/kg per day was started.
Despite treatment the general condition of the patient worsened in the following days, presenting unconsciousness. Cerebrospinal fluid analysis was unremarkable. There was a progressive lowering of consciousness into a coma and she died a few days later.
In conclusion, this is a case of visceral leishmaniasis with duodenal involvement (and likely involvement in oral mucosa) in a patient 6-months after allogeneic UCB SCT. In endemic areas for this parasite, we must take into account the possibility of visceral leishmaniasis in all patients with symptoms suggestive of this condition, that sometimes may have an unusual localization and resemble gastrointestinal GVHD. It is important both an early diagnosis and treatment as it is associated with high mortality even in spite of its rapid treatment. Letter to the Editor
